Overview

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Status:
Unknown status

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

To study the activity of chemotherapy with Gemzar-carboplatin in the preoperative setting for operable stages of non-small-cell lung cancer and to identify novel molecular markers correlated with chemosensitivity and prognosis

Phase:

Phase 2

Details

Lead Sponsor:

Hospital Authority, Hong Kong

Collaborator:

Eli Lilly and Company

Treatments:

Carboplatin
Gemcitabine